Philip L. Johnson
Chief Financial Officer, Jazz Pharmaceuticals.
Companies
- Jazz PharmaceuticalsChief financial officer Mar 5, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ56,431 shares2$12.1M at $214.42Jun 30, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Shares withheld for tax 3,343 shares at $237.72 of Jazz Pharmaceuticals2
- Mar 5, 2026Shares withheld for tax 2,615 shares at $188.69 of Jazz Pharmaceuticals3
- Feb 26, 2026Granted 11,857 shares of Jazz Pharmaceuticals4
- Mar 5, 2025Returned to company 1,149 shares at $138.95 of Jazz Pharmaceuticals5
- Feb 27, 2025Granted 7,704 shares of Jazz Pharmaceuticals6
- Feb 27, 2025Granted 15,407 shares of Jazz Pharmaceuticals6
- Mar 1, 2024Bought 12,000 shares at $119.65 of Jazz Pharmaceuticals7
- Mar 1, 2024Granted 15,932 shares of Jazz Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 9, 2026
- 4SEC EDGARForm 4 filed Mar 2, 2026
- 5SEC EDGARForm 4 filed Mar 7, 2025
- 6SEC EDGARForm 4 filed Mar 3, 2025
- 7SEC EDGARForm 4 filed Mar 5, 2024